O
Omaprakash
About Omaprakash
Omaprakash has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Pantheon M-Healthcare Private Limited and E2r Online Services Private Limited. Formerly with 2 companies, such as Vital Event Management Private Limited and Ssemerging Marketing Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Pantheon M-Healthcare Private Limited
U74140DL2015PTC277150
|
Director | 03 Jun 2020 | 2015 | Active |
E2r Online Services Private Limited
U74999DL2016PTC302900
|
Director | 20 Aug 2020 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Vital Event Management Private Limited
U92490DL2020PTC363727
|
Director | 15 May 2020 | 2020 | Active |
Ssemerging Marketing Private Limited
U52100DL2015PTC276042
|
Director | 04 Jan 2020 | 2015 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Omaprakash
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omaprakash
Omaprakash has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Pantheon M-Healthcare Private Limited and E2r Online Services Private Limited. Formerly with 2 companies, such as Vital Event Management Private Limited and Ssemerging Marketing Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Omaprakash is associated with 2 companies as Director.
Omaprakash has expertise in Healthcare, General Business.
Omaprakash has 6 years in corporate governance.